USFDA completes inspection of Lupin’s Pithampur facility

12 Feb 2020 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Lupin’s Pithampur unit-1 facility. The inspection was carried out between February 3, 2020 and February 11, 2020. The inspection for the Pithampur unit-1 facility closed with two 483 observations.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2353.70 6.25 (0.27%)
27-Mar-2026 11:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.10
Dr. Reddys Lab 1298.05
Cipla 1242.05
Zydus Lifesciences 906.20
Lupin 2353.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×